Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Watts Ryan J.. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Watts Ryan J. har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:DNLI / Denali Therapeutics Inc. President and CEO, Director 2.152.604
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Watts Ryan J.. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Watts Ryan J. som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-09-05 2025-09-03 4 DNLI Denali Therapeutics Inc.
Common Stock
G - Gift -50.000 2.152.604 -2,27
2025-07-11 2025-07-09 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -495.282 253.071 -66,18 15,00 -7.429.230 3.796.065
2025-07-11 2025-07-09 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 40.000 748.353 5,65 5,28 211.200 3.951.304
2025-07-11 2025-07-09 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 455.282 708.353 179,90 0,68 309.592 481.680
2025-01-08 2025-01-07 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -7.650 253.071 -2,93 20,81 -159.196 5.266.408
2025-01-08 2025-01-06 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -29.266 260.721 -10,09 20,22 -591.759 5.271.779
2025-01-07 2025-01-03 4 DNLI Denali Therapeutics Inc.
Common Stock
A - Award 54.180 289.987 22,98
2024-10-22 2024-10-18 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -40.000 235.807 -14,50 27,69 -1.107.600 6.529.496
2024-10-22 2024-10-18 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 40.000 275.807 16,96 0,68 27.200 187.549
2024-08-22 2024-08-20 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -2.260 235.807 -0,95 23,79 -53.765 5.609.849
2024-03-29 2024-03-29 4 DNLI Denali Therapeutics Inc.
Common Stock
G - Gift -40.000 2.202.604 -1,78
2024-02-15 2024-02-13 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -9.589 238.067 -3,87 17,29 -165.794 4.116.178
2024-01-11 2024-01-09 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -7.818 2.268.363 -0,34 19,78 -154.640 44.868.220
2024-01-09 2024-01-05 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -17.483 2.276.181 -0,76 19,43 -339.695 44.226.197
2024-01-05 2024-01-03 4 DNLI Denali Therapeutics Inc.
Common Stock
A - Award 89.520 272.957 48,80
2023-08-23 2023-08-21 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -2.309 2.242.604 -0,10 22,59 -52.160 50.660.424
2023-08-14 2023-08-10 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.526 2.239.913 -0,11 25,03 -63.226 56.065.022
2023-08-14 2023-08-10 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 2.526 2.242.439 0,11 0,68 1.718 1.524.859
2023-06-20 2023-06-16 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -50.000 2.239.913 -2,18 31,40 -1.570.000 70.333.268
2023-06-20 2023-06-16 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 50.000 2.289.913 2,23 0,68 34.000 1.557.141
2023-04-24 2023-04-21 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -24.800 2.239.913 -1,10 25,15 -623.720 56.333.812
2023-04-24 2023-04-21 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 24.800 2.264.713 1,11 0,68 16.864 1.540.005
2023-04-24 2023-04-20 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -200 2.239.913 -0,01 25,00 -5.000 55.997.825
2023-04-24 2023-04-20 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 200 2.240.113 0,01 0,68 136 1.523.277
2023-02-15 2023-02-13 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -25.000 2.239.913 -1,10 30,08 -752.000 67.376.583
2023-02-15 2023-02-13 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 25.000 2.264.913 1,12 0,68 17.000 1.540.141
2023-02-15 2023-02-13 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -8.815 2.239.913 -0,39 30,09 -265.243 67.398.982
2023-02-13 2023-02-10 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -25.000 2.229.031 -1,11 29,10 -727.500 64.864.802
2023-02-13 2023-02-10 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 25.000 2.254.031 1,12 0,68 17.000 1.532.741
2023-02-13 2023-02-09 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -3.433 2.229.031 -0,15 30,59 -105.015 68.186.058
2023-01-09 2023-01-05 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -4.800 2.223.664 -0,22 28,44 -136.512 63.241.004
2023-01-05 2023-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -5.029 2.213.464 -0,23 28,73 -144.483 63.592.821
2023-01-05 2023-01-03 4 DNLI Denali Therapeutics Inc.
Common Stock
A - Award 82.240 231.934 54,94
2022-08-23 2022-08-19 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -2.404 2.202.993 -0,11 33,22 -79.861 73.183.427
2022-02-15 2022-02-11 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -9.491 2.129.648 -0,44 34,72 -329.528 73.941.379
2022-02-11 2022-02-10 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
M - Exercise -6.118 0 -100,00
2022-02-11 2022-02-10 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
M - Exercise -64.631 0 -100,00
2022-02-11 2022-02-10 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 6.118 260.640 2,40 9,60 58.733 2.502.144
2022-02-11 2022-02-10 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 64.631 254.522 34,04 5,28 341.252 1.343.876
2022-02-11 2022-02-09 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -2.719 2.119.442 -0,13 37,55 -102.104 79.589.074
2022-01-07 2022-01-05 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -5.007 2.113.361 -0,24 44,78 -224.213 94.636.306
2022-01-05 2022-01-03 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
A - Award 186.500 186.500
2022-01-05 2022-01-03 4 DNLI Denali Therapeutics Inc.
Common Stock
A - Award 62.000 213.691 40,87
2021-12-03 2021-12-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -805 2.103.368 -0,04 46,35 -37.312 97.491.107
2021-12-03 2021-12-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -9.012 2.104.173 -0,43 45,30 -408.244 95.319.037
2021-12-03 2021-12-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -8.516 2.113.185 -0,40 44,39 -378.025 93.804.282
2021-11-03 2021-11-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -16.674 2.121.701 -0,78 49,87 -831.532 105.809.229
2021-11-03 2021-11-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.659 2.138.375 -0,08 48,61 -80.644 103.946.409
2021-10-05 2021-10-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -4.247 2.140.034 -0,20 50,99 -216.555 109.120.334
2021-10-05 2021-10-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -10.782 2.144.281 -0,50 50,44 -543.844 108.157.534
2021-10-05 2021-10-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -3.304 2.155.063 -0,15 49,38 -163.152 106.417.011
2021-09-03 2021-09-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -10.892 2.158.367 -0,50 54,92 -598.189 118.537.516
2021-09-03 2021-09-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -7.441 2.169.259 -0,34 54,27 -403.823 117.725.686
2021-08-23 2021-08-19 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -750 2.176.700 -0,03 49,97 -37.478 108.769.699
2021-08-23 2021-08-19 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -1.626 2.177.450 -0,07 49,38 -80.292 107.522.481
2021-08-04 2021-08-02 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -9.790 2.174.076 -0,45 51,94 -508.493 112.921.507
2021-08-04 2021-08-02 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -8.543 2.183.866 -0,39 50,80 -433.984 110.940.393
2021-07-06 2021-07-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.459 2.192.409 -0,11 77,84 -191.401 170.650.539
2021-07-06 2021-07-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -12.844 2.194.868 -0,58 77,35 -993.471 169.770.845
2021-07-06 2021-07-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -3.030 2.207.712 -0,14 76,38 -231.428 168.622.835
2021-06-03 2021-06-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -354 2.210.742 -0,02 63,50 -22.479 140.382.117
2021-06-03 2021-06-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.102 2.211.096 -0,09 62,76 -131.911 138.757.329
2021-06-03 2021-06-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.750 2.213.198 -0,12 62,09 -170.748 137.417.464
2021-06-03 2021-06-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -13.127 2.215.948 -0,59 60,98 -800.511 135.132.941
2021-05-05 2021-05-03 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -851 2.229.075 -0,04 59,92 -50.989 133.559.487
2021-05-05 2021-05-03 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -3.485 2.229.926 -0,16 59,12 -206.030 131.830.995
2021-05-05 2021-05-03 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -13.997 2.233.411 -0,62 58,45 -818.083 130.536.173
2021-04-05 2021-04-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -4.586 2.247.408 -0,20 57,31 -262.842 128.807.942
2021-04-05 2021-04-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -8.516 2.251.994 -0,38 56,88 -484.356 128.084.411
2021-04-05 2021-04-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -5.232 2.260.510 -0,23 55,52 -290.486 125.505.776
2021-04-05 2021-03-09 4 DNLI Denali Therapeutics Inc.
Common Stock
G - Gift -40.000 2.265.742 -1,73
2021-03-03 2021-03-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -68 2.305.742 0,00 70,92 -4.823 163.532.446
2021-03-03 2021-03-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -594 2.305.810 -0,03 69,65 -41.371 160.595.055
2021-03-03 2021-03-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.625 2.306.404 -0,07 68,46 -111.246 157.894.111
2021-03-03 2021-03-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -3.339 2.308.029 -0,14 67,69 -226.017 156.230.483
2021-03-03 2021-03-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -3.453 2.311.368 -0,15 66,54 -229.780 153.809.984
2021-03-03 2021-03-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -5.885 2.314.821 -0,25 65,63 -386.209 151.912.443
2021-03-03 2021-03-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -3.370 2.320.706 -0,15 64,42 -217.106 149.506.843
2021-02-16 2021-02-11 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -960 2.324.076 -0,04 71,47 -68.610 166.099.388
2021-02-16 2021-02-11 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -8.513 2.325.036 -0,36 70,17 -597.374 163.152.426
2021-02-10 2021-02-09 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -811 2.313.853 -0,04 75,07 -60.883 173.705.572
2021-02-10 2021-02-09 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -1.634 2.314.664 -0,07 74,05 -120.999 171.403.184
2021-02-10 2021-02-09 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -2.667 2.316.298 -0,12 73,24 -195.328 169.643.349
2021-02-10 2021-02-08 4 DNLI Denali Therapeutics Inc.
Restricted Stock Units
M - Exercise -8.800 17.600 -33,33
2021-02-10 2021-02-08 4 DNLI Denali Therapeutics Inc.
Restricted Stock Units
M - Exercise -5.516 0 -100,00
2021-02-10 2021-02-08 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 8.800 2.318.965 0,38
2021-02-10 2021-02-08 4 DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 5.516 2.310.165 0,24
2021-02-02 2021-02-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -560 2.304.649 -0,02 69,69 -39.026 160.610.989
2021-02-02 2021-02-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -3.552 2.305.209 -0,15 69,17 -245.681 159.444.391
2021-02-02 2021-02-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -14.222 2.308.761 -0,61 68,21 -970.111 157.485.205
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
A - Award 180.000 180.000
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Restricted Stock Units
A - Award 60.000 60.000
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.142 2.322.978 -0,05 84,24 -96.204 195.692.545
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.225 2.324.120 -0,05 83,43 -102.198 193.894.592
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -7.410 2.325.345 -0,32 82,44 -610.875 191.699.814
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -7.539 2.332.755 -0,32 81,66 -615.631 190.491.607
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.400 2.340.294 -0,06 80,25 -112.344 187.798.530
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -4.208 2.341.694 -0,18 79,57 -334.838 186.332.572
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -9.482 2.345.902 -0,40 78,41 -743.503 183.946.868
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.740 2.355.384 -0,07 77,29 -134.480 182.041.976
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.620 2.357.124 -0,07 76,07 -123.236 179.310.666
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.100 2.358.744 -0,05 74,52 -81.968 175.765.111
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -7.322 2.359.844 -0,31 73,78 -540.189 174.100.087
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -9.443 2.367.166 -0,40 72,63 -685.852 171.928.924
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -8.683 2.376.609 -0,36 71,77 -623.218 170.579.923
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -11.896 2.385.292 -0,50 70,82 -842.479 168.927.334
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -9.900 2.397.188 -0,41 70,02 -693.181 167.847.029
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.224 2.407.088 -0,05 68,26 -83.552 164.310.715
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.700 2.408.312 -0,07 66,63 -113.265 160.457.399
2021-01-06 2021-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.300 2.410.012 -0,05 65,21 -84.768 157.147.724
2020-08-20 2020-08-18 4 DNLI Denali Therapeutics Inc.
Restricted Stock Units
A - Award 20.000 20.000
2020-06-18 2020-06-18 4 DNLI Denali Therapeutics Inc.
Common Stock
G - Gift -40.000 2.389.304 -1,65
2020-04-01 2020-03-30 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale -4.807 22.013 -17,92 19,48 -93.640 428.813
2020-04-01 2020-02-08 4/A DNLI Denali Therapeutics Inc.
Restricted Stock Units
M - Exercise -8.800 26.400 -25,00
2020-04-01 2020-02-08 4/A DNLI Denali Therapeutics Inc.
Restricted Stock Units
M - Exercise -5.515 5.516 -50,00
2020-04-01 2020-02-08 4/A DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 8.800 26.820 48,83
2020-04-01 2020-02-08 4/A DNLI Denali Therapeutics Inc.
Common Stock
M - Exercise 5.515 18.020 44,10
2020-02-12 2020-02-10 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
A - Award 367.675 367.675
2020-02-12 2020-02-10 4 DNLI Denali Therapeutics Inc.
Restricted Stock Units
A - Award 78.787 78.787
2019-12-05 2019-12-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -18.755 2.429.304 -0,77 18,00 -337.590 43.727.472
2019-12-05 2019-12-03 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.513 2.448.059 -0,10 18,02 -45.284 44.114.023
2019-11-26 2019-11-25 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -42.185 2.450.572 -1,69 18,02 -760.174 44.159.307
2019-11-26 2019-11-22 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.300 2.492.757 -0,05 18,00 -23.400 44.869.626
2019-09-05 2019-09-05 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -4.847 2.494.057 -0,19 18,09 -87.682 45.117.491
2019-09-05 2019-09-03 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -3.734 2.498.904 -0,15 18,00 -67.212 44.980.272
2019-07-03 2019-07-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -18.333 2.502.638 -0,73 20,76 -380.593 51.954.765
2019-07-03 2019-05-14 4 DNLI Denali Therapeutics Inc.
Common Stock
G - Gift -40.000 2.520.971 -1,56
2019-06-05 2019-06-03 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -18.333 2.560.971 -0,71 19,07 -349.610 48.837.717
2019-05-03 2019-05-03 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -6.111 2.579.304 -0,24 24,49 -149.658 63.167.155
2019-05-03 2019-05-02 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -6.111 2.585.415 -0,24 24,03 -146.847 62.127.522
2019-05-03 2019-05-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -6.112 2.591.526 -0,24 24,09 -147.238 62.429.861
2019-04-03 2019-04-03 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -500 2.597.638 -0,02 26,77 -13.385 69.538.769
2019-04-03 2019-04-03 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -5.641 2.598.138 -0,22 26,28 -148.245 68.279.067
2019-04-03 2019-04-02 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.942 2.603.779 -0,11 25,17 -74.050 65.537.117
2019-04-03 2019-04-02 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -3.200 2.606.721 -0,12 24,52 -78.464 63.916.799
2019-04-03 2019-04-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -6.050 2.609.921 -0,23 23,91 -144.656 62.403.211
2019-03-05 2019-03-05 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -6.141 2.615.971 -0,23 21,97 -134.918 57.472.883
2019-03-05 2019-03-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.700 2.622.112 -0,06 22,83 -38.811 59.862.817
2019-03-05 2019-03-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -4.442 2.623.812 -0,17 21,87 -97.147 57.382.768
2019-03-05 2019-03-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -2.050 2.628.254 -0,08 22,91 -46.966 60.213.299
2019-03-05 2019-03-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -4.000 2.630.304 -0,15 22,19 -88.760 58.366.446
2019-02-11 2019-02-08 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
A - Award 281.600 281.600
2019-02-11 2019-02-08 4 DNLI Denali Therapeutics Inc.
Restricted Stock Units
A - Award 35.200 35.200
2019-02-11 2019-02-08 4 DNLI Denali Therapeutics Inc.
Restricted Stock Units
A - Award 11.031 11.031
2019-02-05 2019-02-05 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -8.230 2.634.304 -0,31 18,83 -154.971 49.603.944
2019-02-05 2019-02-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -854 2.642.534 -0,03 19,12 -16.328 50.525.250
2019-02-05 2019-02-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -3.200 2.643.388 -0,12 18,49 -59.168 48.876.244
2019-02-05 2019-02-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -6.050 2.646.588 -0,23 18,65 -112.832 49.358.866
2019-01-04 2019-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -4.933 2.652.638 -0,19 20,02 -98.759 53.105.813
2019-01-04 2019-01-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.300 2.657.571 -0,05 19,18 -24.934 50.972.212
2019-01-04 2019-01-03 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -6.050 2.658.871 -0,23 18,89 -114.284 50.226.073
2019-01-04 2019-01-02 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -1.000 2.664.921 -0,04 20,24 -20.240 53.938.001
2019-01-04 2019-01-02 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -5.050 2.665.921 -0,19 19,42 -98.071 51.772.186
2018-12-06 2018-12-03 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -400 2.670.971 -0,01 19,16 -7.664 51.175.804
2018-12-06 2018-12-03 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -17.933 2.671.371 -0,67 18,42 -330.274 49.198.907
2018-12-06 2018-11-27 4 DNLI Denali Therapeutics Inc.
Common Stock
G - Gift -40.000 2.689.304 -1,47
2018-11-15 2018-11-15 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -13.588 2.729.304 -0,50 18,12 -246.236 49.459.355
2018-11-15 2018-11-13 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -4.746 2.742.892 -0,17 18,00 -85.428 49.372.056
2018-10-03 2018-10-01 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -18.333 2.747.638 -0,66 21,72 -398.193 59.678.697
2018-09-06 2018-09-04 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -18.333 2.765.971 -0,66 19,06 -349.427 52.719.407
2018-08-31 2018-08-29 4 DNLI Denali Therapeutics Inc.
Common Stock
S - Sale X -18.334 2.784.304 -0,65 18,05 -330.929 50.256.687
2018-02-28 2018-02-26 4 DNLI Denali Therapeutics Inc.
Stock Option (right to buy)
A - Award 300.000 300.000
2018-02-28 2017-12-13 4 DNLI Denali Therapeutics Inc.
Common Stock
A - Award 5 12.505 0,04 20,47 102 255.977
2017-12-12 2017-12-12 4 DNLI Denali Therapeutics Inc.
Series B-1 Preferred Stock
C - Conversion -12.500 0 -100,00
2017-12-12 2017-12-12 4 DNLI Denali Therapeutics Inc.
Common Stock
C - Conversion 12.500 12.500
2017-12-07 3 DNLI Denali Therapeutics Inc.
Common Stock
5.605.276
2017-12-07 3 DNLI Denali Therapeutics Inc.
Common Stock
5.605.276
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)